Wells Fargo’s DarioHealth DRIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40 | Hold |
5
| – | – | ﹤0.01% | 6640 |
|
|
2025
Q4 | $57 | Hold |
5
| – | – | ﹤0.01% | 6501 |
|
|
2025
Q3 | $87 | Hold |
5
| – | – | ﹤0.01% | 6401 |
|
|
2025
Q2 | $67 | Hold |
5
| – | – | ﹤0.01% | 6535 |
|
|
2025
Q1 | $61 | Hold |
5
| – | – | ﹤0.01% | 6422 |
|
|
2024
Q4 | $79 | Hold |
5
| – | – | ﹤0.01% | 6442 |
|
|
2024
Q3 | $112 | Hold |
5
| – | – | ﹤0.01% | 6269 |
|
|
2024
Q2 | $119 | Sell |
5
-11
| -69% | -$312 | ﹤0.01% | 6235 |
|
|
2024
Q1 | $479 | Buy |
16
+1
| +7% | +$38 | ﹤0.01% | 6288 |
|
|
2023
Q4 | $531 | Sell |
15
-100
| -87% | -$3.56K | ﹤0.01% | 6369 |
|
|
2023
Q3 | $7.54K | Buy |
115
+102
| +785% | +$6.87K | ﹤0.01% | 5862 |
|
|
2023
Q2 | $1.08K | Sell |
13
-12
| -48% | -$911 | ﹤0.01% | 6308 |
|
|
2023
Q1 | $2.03K | Sell |
25
-7
| -22% | -$687 | ﹤0.01% | 6219 |
|
|
2022
Q4 | $2.74K | Hold |
32
| – | – | ﹤0.01% | 5927 |
|
|
2022
Q3 | $3K | Hold |
32
| – | – | ﹤0.01% | 6043 |
|
|
2022
Q2 | $4K | Sell |
32
-133
| -81% | -$15.6K | ﹤0.01% | 6077 |
|
|
2022
Q1 | $19K | Sell |
165
-235
| -59% | -$38.9K | ﹤0.01% | 6026 |
|
|
2021
Q4 | $103K | Buy |
400
+375
| +1,500% | +$114K | ﹤0.01% | 5616 |
|
|
2021
Q3 | $7K | Sell |
25
-9
| -26% | -$2.6K | ﹤0.01% | 6298 |
|
|
2021
Q2 | $15K | Buy |
34
+6
| +21% | +$2.28K | ﹤0.01% | 6003 |
|
|
2021
Q1 | $11K | Sell |
28
-59
| -68% | -$26.6K | ﹤0.01% | 6309 |
|
|
2020
Q4 | $25K | Hold |
87
| – | – | ﹤0.01% | 5801 |
|
|
2020
Q3 | $30K | Buy |
87
+61
| +235% | +$16.5K | ﹤0.01% | 5654 |
|
|
2020
Q2 | $3K | Hold |
26
| – | – | ﹤0.01% | 6052 |
|
|
2020
Q1 | $3K | Buy |
26
+1
| +4% | +$148 | ﹤0.01% | 5931 |
|
|
2019
Q4 | $3K | Hold |
25
| – | – | ﹤0.01% | 6110 |
|
|
2019
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 6136 |
|
|
2019
Q2 | $5K | Hold |
25
| – | – | ﹤0.01% | 6032 |
|
|
2019
Q1 | $7K | Hold |
25
| – | – | ﹤0.01% | 5687 |
|
|
2018
Q4 | $8K | Buy |
+25
| New | +$8.97K | ﹤0.01% | 5976 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6376 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6330 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6261 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6339 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6287 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6199 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6132 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6242 |
|
Other funds holding DRIO
NCM
VCM
VFT
VGA
Wells Fargo's DRIO Position: Q1 2026 in Review
Wells Fargo held its DarioHealth (DRIO) position steady in Q1 2026 at 5 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #6640.
Wells Fargo first reported a position in DRIO in Q4 2018 and has held it in 30 quarters since. The position peaked at $103K in Q4 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.
- Wells Fargo held 5 shares of DarioHealth worth $40 as of Q1 2026.
- Wells Fargo left its DarioHealth share count unchanged in Q1 2026.
- DarioHealth made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6640 holding.
- Wells Fargo first reported a position in DarioHealth in Q4 2018 and has held it in 30 quarters since.
- Wells Fargo's DarioHealth position peaked at $103K in Q4 2021.
- 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.